RUSSU, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 767
EU - Europa 496
AS - Asia 393
SA - Sud America 5
AF - Africa 2
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.666
Nazione #
US - Stati Uniti d'America 758
CN - Cina 338
IE - Irlanda 182
UA - Ucraina 98
FI - Finlandia 58
SG - Singapore 49
DE - Germania 47
SE - Svezia 35
GB - Regno Unito 32
IT - Italia 16
BE - Belgio 12
CA - Canada 9
FR - Francia 7
BR - Brasile 5
PL - Polonia 3
RU - Federazione Russa 3
AU - Australia 2
JP - Giappone 2
MU - Mauritius 2
PT - Portogallo 2
CH - Svizzera 1
EU - Europa 1
IN - India 1
KG - Kirghizistan 1
KR - Corea 1
TR - Turchia 1
Totale 1.666
Città #
Chandler 183
Dublin 182
Jacksonville 120
Nanjing 82
Beijing 66
Ann Arbor 52
Boardman 45
Singapore 40
Nanchang 36
Ashburn 33
Wilmington 33
Princeton 27
Jiaxing 25
Shenyang 24
Dearborn 23
Lawrence 22
Tianjin 22
Hebei 18
Shanghai 16
Medford 15
Changsha 14
Houston 13
Brussels 12
Helsinki 11
Los Angeles 11
Milan 8
Woodbridge 8
Hangzhou 7
Toronto 7
New York 6
Kunming 5
Norwalk 5
Chicago 4
Pavia 4
Seattle 4
Fairfield 3
Falls Church 3
Krakow 3
Lanzhou 3
Redwood City 3
Saint Petersburg 3
Washington 3
Coimbra 2
Dallas 2
Des Moines 2
Guangzhou 2
Jinan 2
Ningbo 2
Perth 2
Piscataway 2
Santa Clara 2
Tokyo 2
Bishkek 1
Changchun 1
Dolo 1
Garching 1
Haikou 1
Hefei 1
London 1
Lynnwood 1
Ma'anshan 1
Muggiò 1
Newton 1
Ottawa 1
Pune 1
Puyang Chengguanzhen 1
Qingdao 1
Redmond 1
San Francisco 1
Seocho-gu 1
Sunnyvale 1
Surrey 1
São Paulo 1
Tappahannock 1
Verona 1
Xian 1
Zurich 1
Totale 1.249
Nome #
First-order longitudinal population model of FEV1 data: single-trial modeling and meta-analysis 94
Tumor-growth inhibition in preclinical animal studies: steady-state analysis of biomarker-driven models 91
Continuous-time Markov modelling of flexible-dose depression trials 81
Biomarker-driven models of tumor growth inhibition in preclinical animal studies 81
Modeling myelosuppression in patients treated with anticancer drugs 76
Bayesian population approaches to the analysis of dose escalation studies 75
Heart rate correction of the QT interval: a nonparametric individualized approach 71
Integration of response, tolerability and dropout in flexible-dose trials: a case study in depression 71
A state-space approach to disease and dropout modelling in Phase II clinical trials 69
Dose escalation studies: a comparison among Bayesian models 68
Population state-space modelling of patient responses in antidepressant studies 68
Statistical methods to detect immune responses to drug administration 67
Second order Markov modelling of HAMD responses in depression trials 67
A PCA approach to population analysis: with application to a Phase II depression trial 66
Stochastic model search with binary outcomes for genome-wide association studies. 66
PCA-based modelling in antidepressant trials: a pre-mechanistic approach 62
Modelling of the outcome of non-inferiority trials by integration of historical data 59
Disease and dropout modelling in depression trials: a state-space approach 58
Joint Modeling of Efficacy, Dropout, and Tolerability in Flexible-Dose Trials: A Case Study in Depression 58
Dose escalation studies in Phase I clinical trials: a comparison among Bayesian population approaches 57
Population model of longitudinal FEV1 data in asthmatics: meta-analysis and predictability of placebo response 52
A new, second-order indirect model of depression time course 48
Population modelling of patient responses in antidepressant studies: A stochastic approach 43
Bayesian population modelling of Phase I dose escalation studies: Gaussian process vs parametric approaches 43
ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis - A EUSTAR analysis 43
What have multicentre registries across the world taught us about the disease features of systemic sclerosis? 41
Totale 1.675
Categoria #
all - tutte 6.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020162 0 0 0 0 0 20 1 44 15 38 43 1
2020/2021194 23 19 7 22 1 26 5 24 6 29 26 6
2021/2022120 3 2 6 2 4 5 4 8 12 4 16 54
2022/2023489 41 52 10 36 48 48 0 20 211 7 11 5
2023/2024149 21 25 5 11 10 33 7 13 0 11 5 8
2024/202599 11 36 5 9 28 10 0 0 0 0 0 0
Totale 1.675